These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 12117026
1. Benign prostatic hyperplasia in elderly Thai men in an urban community: the prevalence, natural history and health related behavior. Tantiwong A, Nuanyong C, Vanprapar N, Swasdipala P, Chittapraphai S. J Med Assoc Thai; 2002 Mar; 85(3):356-60. PubMed ID: 12117026 [Abstract] [Full Text] [Related]
2. The natural history of benign prostatic hyperplasia. Fitzpatrick JM. BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045 [Abstract] [Full Text] [Related]
4. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey. Suzuki H, Yano M, Awa Y, Nakatsu H, Egoshi K, Mikami K, Ota S, Okano T, Hamano S, Ohki T, Furuya Y, Ichikawa T. Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553 [Abstract] [Full Text] [Related]
5. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. Nickel JC, Elhilali M, Vallancien G, ALF-ONE Study Group. BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082 [Abstract] [Full Text] [Related]
7. The prevalence of prostate cancer screening in Thai elderly. Tantiwong A, Soontrapa S, Sujijantrarat P, Vanprapar N, Sawangsak L. J Med Assoc Thai; 2002 Apr; 85(4):502-8. PubMed ID: 12118499 [Abstract] [Full Text] [Related]
10. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate. Chalise PR, Agrawal CS. Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015 [Abstract] [Full Text] [Related]
18. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. Li MK, Garcia L, Patron N, Moh LC, Sundram M, Leungwattanakij S, Pripatnanont C, Cheng C, Chi-Wai M, Loi-Cheong N. BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205 [Abstract] [Full Text] [Related]
19. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. O'Leary MP, Wei JT, Roehrborn CG, Miner M, BPH Registry and Patient Survey Steering Committee. BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080 [Abstract] [Full Text] [Related]
20. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score. Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z. BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]